Compare MEDP & GPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEDP | GPC |
|---|---|---|
| Founded | 1992 | 1928 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Automotive Aftermarket |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1B | 19.0B |
| IPO Year | 2016 | N/A |
| Metric | MEDP | GPC |
|---|---|---|
| Price | $399.32 | $150.41 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 6 |
| Target Price | ★ $490.00 | $152.17 |
| AVG Volume (30 Days) | 351.3K | ★ 1.1M |
| Earning Date | 02-09-2026 | 02-17-2026 |
| Dividend Yield | N/A | ★ 2.76% |
| EPS Growth | ★ 20.98 | N/A |
| EPS | ★ 15.28 | 5.81 |
| Revenue | $2,530,234,000.00 | ★ $24,060,899,000.00 |
| Revenue This Year | $13.35 | $4.60 |
| Revenue Next Year | $8.44 | $3.68 |
| P/E Ratio | $27.74 | ★ $25.70 |
| Revenue Growth | ★ 19.97 | 3.26 |
| 52 Week Low | $250.05 | $104.01 |
| 52 Week High | $628.92 | $149.80 |
| Indicator | MEDP | GPC |
|---|---|---|
| Relative Strength Index (RSI) | 14.58 | 71.99 |
| Support Level | $538.29 | $136.26 |
| Resistance Level | $597.88 | $149.28 |
| Average True Range (ATR) | 23.88 | 3.10 |
| MACD | -20.58 | 0.62 |
| Stochastic Oscillator | 6.68 | 91.61 |
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Genuine Parts sells aftermarket automotive parts (60% of sales) and industrial products (40% of sales) in the United States and internationally. The automotive segment primarily acts as a distributor to its network of 9,800 global retail locations, of which about two-thirds are independently owned and operated. We estimate Genuine serves around 6,000 retail locations in the US operating under the Napa Auto Parts brand, with about 80% of end-market sales derived from professional customers. Its industrial segment, primarily operating under the Motion name in the United States, is a leading distributor of bearings, power transmission, and other industrial products to more than 200,000 maintenance, repair, and original equipment manufacturer customers.